In summary, blood RGS1 is not only elevated in NSCLC patients, correlating with LYN metastasis and neoadjuvant chemotherapy application, but also possesses a good prognostic value that is meaningful for surgical NSCLC patient management. Here, LYN is linked to non-small cell lung carcinoma.